Henry Ogbeifun
San Antonio,TX
Summary
Translational science professional with 7+ years of experience in oncology research, pharmacovigilance, and real-world evidence. Expertise in bridging clinical data with biological insights to inform precision medicine strategies. Strong background in biomarker interpretation, clinical outcomes analysis, and evidence generation across hematologic malignancies. Proven ability to translate complex datasets into actionable insights supporting drug development and patient stratification.
Overview
9
9
years of professional experience
Work History
Assistant Professor Pharmacotherapy
University of Texas at Austin – College of Pharmacy
07.2023 - Current
- Deliver instruction in sterile compounding and aseptic techniques for PharmD students.
- Facilitate student learning through recitation sessions, academic advising, and examination support.
- Integrate translational science principles into pharmacy education, emphasizing bench-to-bedside applications
Senior Pharmacovigilance Scientist
Mersana Therapeutics
Cambridge, MA
01.2022 - Current
- Lead safety and translational insights for oncology programs, integrating clinical and real-world data to inform therapeutic strategies
- Contribute to biomarker-driven discussions and patient stratification approaches in clinical development
- Perform signal detection and benefit-risk assessment to support precision medicine decision-making
- Collaborate with clinical development and translational teams to align safety findings with biological mechanisms
- Support regulatory submissions with integrated clinical and safety evidence
Pharmacovigilance Scientist
IDRx
Boston, MA
01.2020 - 01.2022
- Analyzed clinical and real-world datasets to generate insights on treatment effectiveness and safety
- Supported translational research efforts by linking patient outcomes with therapeutic response patterns
- Contributed to publications and presentations in oncology, including studies in Mantle Cell Lymphoma
- Collaborated with cross-functional teams to inform clinical development strategies
Pharmacovigilance Specialist
PDL BioPharma
Nevada, USA
01.2017 - 01.2020
- Conducted detailed analysis of adverse event data to support safety and translational insights
- Assisted in integrating clinical and post-marketing data for comprehensive evaluation
- Supported literature review and scientific data synthesis for research and reporting
Education
Ph.D. - Translational Science
University of Austin Texas
San Antonio, TX05-2026
Master of Public Health - Health Policy
University of Alabamam At Birmingham
Birmingham, AL12-2013
Skills
- Programming: R, SAS
- Data Analysis: Excel, SQL (optional)
- Safety Databases: Argus, ARISg
- Coding: MedDRA
- Visualization: PowerPoint, Tableau (optional)
PUBLICATIONS & RESEARCH
- Real-world comparative effectiveness of targeted therapies
- Healthcare utilization and outcomes research in oncology
- Research involving Bruton Tyrosine Kinase Inhibitors and targeted treatments
TRANSLATIONAL & SCIENTIFIC EXPERIENCE
- Experience linking clinical outcomes with biological and therapeutic mechanisms
- Interpretation of treatment response metrics (OS, PFS, TTNT) in oncology
- Exposure to biomarker-informed strategies and targeted therapies
- Development of real-world evidence supporting precision medicine approaches
Timeline
Assistant Professor Pharmacotherapy
University of Texas at Austin – College of Pharmacy
07.2023 - Current
Senior Pharmacovigilance Scientist
Mersana Therapeutics
01.2022 - Current
Pharmacovigilance Scientist
IDRx
01.2020 - 01.2022
Pharmacovigilance Specialist
PDL BioPharma
01.2017 - 01.2020
Ph.D. - Translational Science
University of Austin Texas
Master of Public Health - Health Policy
University of Alabamam At Birmingham